diplomski rad
A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split

Farah, Rinata
Sveučilište u Splitu
Medicinski fakultet

Citirajte ovaj rad

Farah, R. (2018). A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split (Diplomski rad). Split: Sveučilište u Splitu, Medicinski fakultet. Preuzeto s https://urn.nsk.hr/urn:nbn:hr:171:164339

Farah, Rinata. "A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split." Diplomski rad, Sveučilište u Splitu, Medicinski fakultet, 2018. https://urn.nsk.hr/urn:nbn:hr:171:164339

Farah, Rinata. "A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split." Diplomski rad, Sveučilište u Splitu, Medicinski fakultet, 2018. https://urn.nsk.hr/urn:nbn:hr:171:164339

Farah, R. (2018). 'A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split', Diplomski rad, Sveučilište u Splitu, Medicinski fakultet, citirano: 23.03.2024., https://urn.nsk.hr/urn:nbn:hr:171:164339

Farah R. A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split [Diplomski rad]. Split: Sveučilište u Splitu, Medicinski fakultet; 2018 [pristupljeno 23.03.2024.] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:171:164339

R. Farah, "A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split", Diplomski rad, Sveučilište u Splitu, Medicinski fakultet, Split, 2018. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:171:164339

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.